\r\n The old traders’ adage “better to travel than arrive” has been true in 2017. Last year wa...
\r\n President Donald Trump signed on 28 March 2017 an executive order to unravel former President B...
\r\n According to some scientists, the fingerprint of human-caused climate change has been found on ...
\r\n Australia’s federal government has announced it will ratify and implement the OPCAT Treaty, O...
\r\n Nurses and teachers are among those bearing the brunt of a debt crisis rooted in the mistaken b...

Follow us



Africa's pharmaceutical industry is rapidly growing, as its  broader economy. This growth is driven by a small number of countries: South Africa, Nigeria, Ghana, some Eastern African countries and North Africa. Other emerging countries around the world are showing their capacities in the pharmaceutical sector: during the last years, China's pharmaceutical industry  has grown 20%, Russia's 14%, India's 11% and Brazil's 7%.

The African pharmaceutical sector’s growth stems from increasing number of Africans with high incomes and spending power, fast urbanization and economic growth in most parts of the continent. It is important to highlight that investments in the pharmaceutical sector are investments in the health sector, which also means immense job creation prospects all along the pharmaceutical value chain.

The African pharmaceutical industry is based more on small and privately owned companies, which serve their national markets, than large manufacturers (as Aspen in South Africa) or public sector manufacturers, which are less developed on the ground.

Africa suffers from the worst diseases in the world: 75% of the worldwide HIV/AIDS cases, 90% of the deaths from malaria and the majority of tuberculosis cases are all in Africa. These data clarify that the need of drugs is an emergency. In addition, there is an increasing number of non-communicable diseases which raise the need of specialized medical services and treatments.

Inorder to remove financial barriers to medicines and enhance access to essential medicines, it is necessary to develop the pharmaceutical industry on the continent. The African Development Bank is promoting an agenda to support its regional member countries towards the achievement of several goals: improving access to affordable and quality medicines, job creation in the pharmaceutical sector, dialogue between private and public actors in order to face the challenges that the sector is posing to the African economy.


The gLAWcal Team

Tuesday, June 10, 2014

(Source: All Africa)

This news has been realized by gLAWcal—Global Law Initiatives for Sustainable Development in collaboration with the University Institute of European Studies (IUSE) in Turin, Italy and the University of Piemonte Orientale, Novara, Italy which are both beneficiaries of the European Union Research Executive Agency IRSES Project “Liberalism in Between Europe And China” (LIBEAC) coordinated by Aix-Marseille University (CEPERC). This work has been realized in the framework of Workpackages 4, coordinated by University Institute of European Studies (IUSE) in Turin, Italy.